MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update ...

MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update Continued to make significant progress with the development of the Nanobody® sonelokimab across ...

Asymptomatic spinal cord compression (ASCC) is more common, but its significance is poorly defined. This study investigates if: (1) ASCC can be automatically diagnosed using spinal cord shape analysis ...

Revisions to classification criteria ‘will ensure homogeneous trial populations’ with data-driven scoring, a standardized MRI ...

A surgical team at the University of Maryland Medical Center (UMMC) extracted the tumors, which had wrapped around the spinal cord, through the patient’s eye socket. This was the first time ...

To explore the role of brain and spinal cord MRI features in differentiating patients with suspected central nervous system (CNS) inflammatory diseases.Prospective data from 125 patients undergoing ...

Plano-based Texas Back Institute is joining Aclarion’s Clarity trial for augmented intelligence spine diagnostics. The Clarity trial is examining the Nociscan diagnostic tool’s clinical and economic ...

Researchers have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ever before. Aortic stenosis is a progressive and potentially fatal condition ...

University of East Anglia scientists have developed cutting-edge MRI technology to diagnose a common heart problem more ...

Normal pressure hydrocephalus, a condition in which cerebrospinal fluid builds up in the brain, can lead to issues such as ...

Background: Beside symptoms and clinical signs radiological findings are crucial in the diagnosis of lumbar spinal stenosis (LSS). We investigate which quantitative radiological signs are ...

Keio University doctors said they have taken a promising step toward using human induced pluripotent stem (iPS) cells to treat spinal cord injuries. At a March 21 news conference, Hideyuki Okano ...